LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

<
<<
Previous
Page 1 of 166
Next
>>
>
1 to 25 of 4140 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Timepoint	Timepoint Unit	Mean Total Cell Count Before Treatment	Mean Total Cell Count After Treatment	Mean Total Control Cell Count	Mean Relative Cell Count	Mean Normalized Growth Rate Inhibition Value
MCF7	Imatinib	0.04	uM	LJP6	72	hr	1235	4481	4056	1.1045	1.1187
MCF7	Crizotinib	0.04	uM	LJP5	72	hr	1235	3325	4267	0.7794	0.7387
MCF7	JW-7-24-1	0.04	uM	LJP6	72	hr	1235	2487	4056	0.6129	0.5030
MCF7	Tozasertib	0.04	uM	LJP5	72	hr	1235	1440	4267	0.3377	0.0894
MCF7	CGP60474	0.04	uM	LJP6	72	hr	1235	604	4056	0.1487	-0.3425
MCF7	PD173074	0.04	uM	LJP6	72	hr	1235	4512	4056	1.1128	1.1288
MCF7	HG-6-64-01	0.04	uM	LJP6	72	hr	1235	4834	4056	1.1918	1.2152
MCF7	Neratinib	0.04	uM	LJP5	72	hr	1235	3207	4267	0.7514	0.7040
MCF7	HG-5-113-01	0.04	uM	LJP5	72	hr	1235	3513	4267	0.8246	0.7956
MCF7	Dasatinib	0.04	uM	LJP6	72	hr	1235	1127	4056	0.2781	-0.0520
MCF7	NVP-TAE684	0.04	uM	LJP6	72	hr	1235	2633	4056	0.6499	0.5548
MCF7	CGP60474	0.04	uM	LJP5	72	hr	1235	4211	4267	0.9887	0.9876
MCF7	AT-7519	0.04	uM	LJP6	72	hr	1235	3560	4056	0.8771	0.8520
MCF7	HG-5-88-01	0.04	uM	LJP6	72	hr	1235	2625	4056	0.6466	0.5496
MCF7	Seliciclib	0.04	uM	LJP5	72	hr	1235	4831	4267	1.1327	1.1447
MCF7	AZD7762	0.04	uM	LJP6	72	hr	1235	1904	4056	0.4696	0.2871
MCF7	GW843682X	0.04	uM	LJP6	72	hr	1235	3022	4056	0.7449	0.6839
MCF7	AZD8055	0.04	uM	LJP6	72	hr	1235	1307	4056	0.3227	0.0327
MCF7	Sorafenib	0.04	uM	LJP6	72	hr	1235	3940	4056	0.9719	0.9672
MCF7	CP724714	0.04	uM	LJP5	72	hr	1235	3247	4267	0.7619	0.7178
MCF7	Dasatinib	0.04	uM	LJP5	72	hr	1235	2621	4267	0.6157	0.5235
MCF7	CP466722	0.04	uM	LJP5	72	hr	1235	4851	4267	1.1371	1.1490
MCF7	Alvocidib	0.04	uM	LJP6	72	hr	1235	1126	4056	0.2776	-0.0528
MCF7	KIN001-043	0.04	uM	LJP6	72	hr	1235	3928	4056	0.9685	0.9632
MCF7	BMS345541	0.04	uM	LJP6	72	hr	1235	4482	4056	1.1046	1.1188

<
<<
Previous
Page 1 of 166
Next
>>
>
1 to 25 of 4140 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)